Twenty Years of HIV Research: From Discovery to Understanding
joint with HIV Vaccine Development: Immunological and Biological Challenges
Organizer(s): Jay A. Levy, Alan L. Landay and Richard B. GaynorDate: March 29 - April 04, 2003
Location: Fairmont Banff Springs, Banff, AB, Canada
Research on HIV/AIDS has defined new biologic processes involving HIV accessory genes and novel host immune responses including innate and adaptive immune activities. Moreover, the recognition of recombinant viruses may prove a challenge to antiviral strategies. Current antiviral drugs have prolonged the life of infected people but the emergence of drug resistance and drug toxicities calls for new avenues, particularly immune-based therapies. Approaches for inducing protective immune responses against HIV can be helpful for therapy and vaccine development. The 2003 Keystone Symposium will be dedicated to the knowledge gained in the 20 years since the discovery of HIV. The conference will deal with major issues in viral pathogenesis and the host immune responses to the virus by bringing together pioneers, well-known scientists and young investigators dedicated to reviewing the progress made. The sessions will assess new findings and address novel approaches for arresting viral replication within the infected host and define new directions in therapy and prevention.
Discounted Abstract Deadline: December 31 2002
Discounted Registration Deadline: January 29 2003
We gratefully acknowledge additional support for this conference from: